Biosecurity a no-show

In March, the Department of Health and Human Services (HHS) created the US National Science Advisory Board for Biosecurity, meant to be the centerpiece of a new national system to prevent bioterrorists from seeing research they could transform into bioweapons (see http://www.the-scientist.com/news/20040305/04). But since then, the board has never met, its members have not been chosen, and its professional staff is not yet in place. As of earlier this month, the news page of its Web site had not

Written byJohn Dudley Miller
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In March, the Department of Health and Human Services (HHS) created the US National Science Advisory Board for Biosecurity, meant to be the centerpiece of a new national system to prevent bioterrorists from seeing research they could transform into bioweapons (see http://www.the-scientist.com/news/20040305/04). But since then, the board has never met, its members have not been chosen, and its professional staff is not yet in place. As of earlier this month, the news page of its Web site had not been updated since June 22.

A committee of the National Academy of Sciences (NAS) proposed the board as a self-policing body of scientists necessary to preempt the federal government from taking more drastic measures, such as classifying some research as secret and outlawing its publication. Gerald Fink, the Massachusetts Institute of Technology professor who chaired the NAS report, says he has no idea why the committee hasn't already geared up. Back ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies